US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.30

-0.1066-0.34%

Post-market: 31.26-0.0434-0.14%19:30 EDT

Volume:2K

Turnover:77.92K

Market Cap:50.83M

PE:- -

High:31.42

Open:31.22

Low:31.20

Close:31.41

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.34

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

10x Genomics (TXG) Could Be 31% Above Fair Value After Its Sharp Rally

Simply Wall St.

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)

Argenx Se : Wells Fargo Raises Target Price to $1415 from $1350

THOMSON REUTERS

Argenx : UBS Raises to Buy from Neutral

THOMSON REUTERS

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

10x Genomics (TXG) Stock Looks Above Fair Value After Atera Optimism

Simply Wall St.

Revvity Inc. Stock Outperforms Competitors Despite Losses on the Day

Danaher CEO Rainer Blair Sells 58,255 Shares Worth $12.74 Million

Thermo Fisher CEO Marc N. Casper Disposes of $15.43 Million in Common Shares

European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading

MT Newswires Live

Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages

Qiagen Names Jonathan Pratt as CEO, Effective Sept. 1

Canada's Nanalysis Q2 Revenue Edges up on Services Strength

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)

Cytek Owes Beckman Coulter $56 Mln in Cell-Analysis Patent Case, US Jury Says

William O'Neil Initiates Thermo Fisher Scientific at Buy

MT Newswires Live

Revvity Inc. Stock Advances 3.9%, Outperforms Peers

Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million

Danaher Unit IDT Expands DNA Synthesis Capabilities to Support High-Diversity Assays

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/FMED/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":31.3034,"timestamp":1789502400000,"preClose":31.41,"halted":0,"volume":2488,"hourTrading":{"tag":"盘后","latestPrice":31.26,"preClose":31.3034,"latestTime":"19:30 EDT","volume":7,"amount":219.1238,"timestamp":1789515005451,"change":-0.0434,"changeRate":-0.001386,"amplitude":0},"delay":0,"changeRate":-0.003393823623049992,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Closed","change":-0.1066,"latestTime":"09-15 16:00:00 EDT","open":31.22,"high":31.42,"low":31.2001,"amount":77919.318352,"amplitude":0.007001,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":31.41,"sharesOutstanding":2323806,"nav":30.831238,"aum":50953312.669446,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.26,"preClose":31.3034,"latestTime":"19:30 EDT","volume":7,"amount":219.1238,"timestamp":1789515005451,"change":-0.0434,"changeRate":-0.001386,"amplitude":0},"volumeRatio":0.344799,"impliedVol":0.0711,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.344799,"shares":1623806,"dividePrice":0,"high":31.42,"amplitude":0.007001,"preClose":31.41,"low":31.2001,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":31.3034,"eps":0,"divideRate":0,"volume":2488,"delay":0,"ttmEps":0,"open":31.22,"prevYearClose":27.05,"prevWeekClose":31,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":31.542,"twentyDayClose":30.5871,"sixtyDayClose":26.1028},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662744401","title":"10x Genomics (TXG) Could Be 31% Above Fair Value After Its Sharp Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744401","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744401?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:31","pubTimestamp":1787769077,"startTime":"0","endTime":"0","summary":"10x Genomics (TXG) has drawn investor attention after recent share price gains over the past month and past 3 months. The stock closed at $64.72 on 26 August 2026, with recent returns significantly higher than its 1-year figure.\nFor you as an investor, the recent momentum in 10x Genomics is hard to ignore. The 30 day share price return is 39.87% and the 90 day share price return is 153.70%, while the 1 year total shareholder return of 361.30% contrasts with a 5 year total shareholder return...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-could-be-31-above-fair-value-after-its-shar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-could-be-31-above-fair-value-after-its-shar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4121","LU1861559042.SGD","LU0963586101.USD","LU1861558580.USD","FMED","TXG","ARKG","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748238","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748238","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748238?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:13","pubTimestamp":1787757227,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, declining 0.46% to 1,977.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago  and biopharmaceutical company argenx , which advanced 2.9% and 2.6% respectively. They were followed by semiconductor company Sequans Communications  and 3D printer company Materialise , which rose 2% and 1.2% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and software firm SAP , which fell 3.5% and 2.7% respectively. They were followed by telecommunications company Ericsson  and pharmaceutical company Novo Nordisk , which lost 2.1% and 1.8% respectively.The gainers from the UK were led by biopharmaceutical companies Amarin  and Akari Therapeutics , which climbed 7.1% and 2.9% respectively. They were followed by tobacco company British American Tobacco  and biopharmaceuti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0823416689.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","BK4588","BCYC","LU1093756168.USD","NVOX","BK4139","BK4554","IE0009355771.USD","IE00BJT1NW94.SGD","MREO","DBVT","IE00B2B36J28.USD","TRVG","BDRX","NICO","IE0034235188.USD","OZEM","LU2324357040.USD","BK4591","BK4515","BK4613","BK4141","IE00B4R5TH58.HKD","AUTL","LU0648005311.SGD","TBXU","BK4532","DAVA","LU0084288595.USD","BK4077","ARGX","NVOC","THNR","BK4075","FMED","IE0002141913.USD","LU0006061336.USD","NVO","BK4546","IBB","BK4020","BK4585","NVOH","BK4023","MTLS","LU1093756325.SGD","PPH","LU2543165471.USD","PRNT","LU0154236417.USD","SQNS","LU1983260115.SGD","BK4007","LU0072461881.USD","LU0320765992.SGD","LU0162691827.USD","LU0889565916.HKD","BK4528","AKTX","BK4599","LU0109394709.USD","SAP","BTI","ERIC","AMRN","IE00BKVL7J92.USD","BK4134","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662239718","title":"Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662239718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662239718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:50","pubTimestamp":1787741417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Solventum Corporation (SOLV), Argenx Se (ARGX) and S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0823416689.USD","LU0889565916.HKD","XBI","IE00B2B36J28.USD","SYRE","HCSG","FMED","BK4137","BK4585","LU1983260115.SGD","IE00BJT1NW94.SGD","LU0128526141.USD","XLV","IE0002141913.USD","LU0109394709.USD","LABU","LU0029874061.USD","IBB","LU0320765992.SGD","TBXU","LFSC","BK4505","BK4139","IE0009355771.USD","ARGX","SOLV","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0034235188.USD","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279030","title":"Argenx Se : Wells Fargo Raises Target Price to $1415 from $1350","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662279030?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:31","pubTimestamp":1787740307,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983260115.SGD","LU0320765992.SGD","IE0009355771.USD","IBB","LU0109394709.USD","IE00BJT1NW94.SGD","BK4139","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","BK4505","ARGX","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4585","LU2324357040.USD","IE0034235188.USD","TBXU","LU0823416689.USD","FMED","BK4588","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795371","title":"Argenx : UBS Raises to Buy from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795371?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:55","pubTimestamp":1787730900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nAZN4TGDPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FMED","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4505","LU0889565916.HKD","LU0320765992.SGD","LU1983260115.SGD","ARGX","LU0823416689.USD","TBXU","BK4585","IE0034235188.USD","LU2324357040.USD","BK4139","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IBB","BK4588","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662075781","title":"Revvity Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662075781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662075781?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:14","pubTimestamp":1787692440,"startTime":"0","endTime":"0","summary":"DJ Revvity Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  rose 1.50% to $124.84 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.Revvity Inc. closed 0.10% below its 52-week high of $124.97, which the company reached on August 21st.The stock outperformed some of its competitors Tuesday, as Danaher Corp.  rose 0.40% to $215.97, IDEXX Laboratories Inc.  fell 1.70% to $550.01, and Agilent Technologies Inc.  rose 0.87% to $154.77.Trading volume  remained 459,890 below its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","LU0289739343.SGD","LU0345774391.USD","LU1923621640.USD","LU1057294990.SGD","LU2125910336.SGD","SGXZ57979304.SGD","IE00BQXX3D17.EUR","SGXZ23171101.USD","BK4534","IE00BLDYK493.USD","BK4082","LU1061106388.HKD","LU1366333091.USD","A","LU2244417387.USD","LU1721429402.USD","IE0004445239.USD","LU0528227936.USD","LU1023059063.AUD","LU2413666426.HKD","LU0690374615.EUR","LU0820561818.USD","DHR","LU0114720955.EUR","LU0690374961.EUR","SG9999013999.USD","LU1791710400.SGD","IDXX","PAWZ","GB00B4LPDJ14.GBP","LU1923622614.USD","IE00BN0W2T93.GBP","LU0157215616.USD","LU1721429741.USD","RVTY","LU2229751404.USD","IE000M9KFDE8.USD","LU0109391861.USD","LU1721428933.USD","LU1551013342.USD","LU0320765059.SGD","LU1989771016.USD","LU1804176565.USD","LU2265009873.SGD","FMED","LU0289960550.SGD","LU2092937221.SGD","IE00BN0W2V16.EUR","LU1941712348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759962","title":"10x Genomics (TXG) Stock Looks Above Fair Value After Atera Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759962","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759962?lang=en_us&edition=fundamental","pubTime":"2026-08-26 01:16","pubTimestamp":1787678191,"startTime":"0","endTime":"0","summary":"10x Genomics stock has delivered a very strong 353.4% return over the past year, yet broader valuation checks suggest the shares are not a clear bargain at current levels. With expectations high around its Atera spatial biology platform and expanding clinical collaborations, the key issue for investors is whether the recent price move already reflects much of that optimism.\n\nOver the last 12 months, 10x Genomics has returned 353.4%, which puts extra focus on whether recent gains leave much...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-above-fair-value-after-atera-op","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-above-fair-value-after-atera-op","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0963586101.USD","LU1861558580.USD","LU1861559042.SGD","BK4585","TXG","FMED","TSPA","BK4548","ARKG","CDIG","BK4121","TACU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209767","title":"Revvity Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209767?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:13","pubTimestamp":1787605980,"startTime":"0","endTime":"0","summary":"DJ Revvity Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  shed 1.40% to $123.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.26% to 53,417.16 and the S&P 500 Index  falling 0.28% to 7,652.86.The stock's fall snapped a three-day winning streak.Revvity Inc. closed 1.58% below its 52-week high of $124.97, which the company achieved on August 21st.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Danaher Corp.  fell 1.71% to $215.11, IDEXX Laboratories Inc.  rose 0.46% to $559.51, and Agilent Technologies Inc.  fell 3.50% to $153.43.Trading volume  eclipsed its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0107464264.USD","LU0312595415.SGD","LU2125910336.SGD","LU2265009873.SGD","LU0175139822.USD","LU2063271972.USD","A","LU1974910355.USD","LU2413666426.HKD","IE00BN0W2V16.EUR","GB00B4QBRK32.GBP","LU1923622614.USD","LU2211814178.USD","RVTY","SGXZ57979304.SGD","IE00B64QTZ34.USD","LU0122379950.USD","LU1061106388.HKD","IDXX","LU1941712348.USD","IE00BKVL7J92.USD","LU0511384066.AUD","LU0289739343.SGD","LU0289960550.SGD","BK4082","IE00BQXX3F31.USD","PAWZ","LU0187121727.USD","LU0157215616.USD","LU0289961442.SGD","IE0004445239.USD","LU1721429741.USD","SG9999001176.SGD","LU2041044095.USD","LU2023250504.SGD","LU1989771016.USD","IE00BN0W2W23.USD","LU0820561818.USD","LU1023059063.AUD","LU2125909593.SGD","LU0943347566.SGD","IE00BN0W2T93.GBP","LU1791710400.SGD","LU0689472784.USD","LU2404859741.USD","LU0114720955.EUR","DHR","LU2229751404.USD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098522","title":"Danaher CEO Rainer Blair Sells 58,255 Shares Worth $12.74 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098522","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098522?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:01","pubTimestamp":1787605299,"startTime":"0","endTime":"0","summary":"Danaher CEO Rainer Blair sells 58,255 shares worth $12.74 millionDanaher President and CEO Rainer Blair sold 58,255 common shares on Aug. 21.Sales were executed through a trust at weighted average pri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL62T2rs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Danaher CEO Rainer Blair Sells 58,255 Shares Worth $12.74 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ23171101.USD","LU0107464264.USD","LU0943347566.SGD","SG9999001176.SGD","LU2211814178.USD","LU2063271972.USD","LU0390134368.USD","IE000M9KFDE8.USD","LU0109391861.USD","BK4534","LU0187121727.USD","IE00BQXX3D17.EUR","LU0672654240.SGD","LU1974910355.USD","LU2106854487.HKD","LU2125909247.SGD","LU1791710582.SGD","BK4121","LU0820562030.AUD","LU1917777945.USD","DHR","SG9999001176.USD","BK4581","LU0122379950.USD","LU2355687059.USD","LU2125909593.SGD","FMED","LU0312595415.SGD","LU0157215616.USD","LU1923622614.USD","LU1551013425.SGD","BK4588","LU0175139822.USD","LU2265009873.SGD","LU1057294990.SGD","LU0289739343.SGD","BK4585","LU0708995401.HKD","LU0882574055.USD","IE0004445239.USD","SG9999013999.USD","LU1267930730.SGD","BK4504","BK4533","LU2125910336.SGD","LU0114720955.EUR","LU1023059063.AUD","IE00BQXX3C00.GBP","LU2125910179.SGD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205037","title":"Thermo Fisher CEO Marc N. Casper Disposes of $15.43 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205037","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205037?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:03","pubTimestamp":1787601808,"startTime":"0","endTime":"0","summary":"Thermo Fisher CEO Marc N. Casper disposes of $15.43 million in common sharesThermo Fisher Chairman and CEO Marc N. Casper sold 19,000 common shares on Aug. 20-21.Sales prices ranged from USD 625.45 to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL6VFFCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher CEO Marc N. Casper Disposes of $15.43 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMO","LU1023059063.AUD","LU0070302665.USD","LU0266013472.USD","IE00B19Z9505.USD","LU1815333072.USD","LU0310800379.SGD","LU2112291526.USD","LU2089984988.USD","LU2092937221.SGD","HRTS","LU0061474960.USD","GNMX","LU0320765489.SGD","LU0029864427.USD","LU2543165471.USD","FMED","LU0708994859.HKD","BK4581","BK4534","TMED","GB00BDT5M118.USD","LU1153585028.USD","IE0034235188.USD","IE00B1BXHZ80.USD","LU0345770308.USD","IE0009355771.USD","LU1623119135.USD","IE00B4R5TH58.HKD","LU2433249047.HKD","LU2264538146.SGD","LU2211815571.USD","IE00BQXX3C00.GBP","LU0640476718.USD","LU2357305700.SGD","LU2298321311.HKD","LU0011850046.USD","LU2125909593.SGD","LU2125909247.SGD","LU2468319806.SGD","LU2041044095.USD","BK4588","LU0316494557.USD","LU1057294990.SGD","LU2360108059.USD","LU1548497426.USD","LU1061106388.HKD","BK4566","LU1720051108.HKD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661277966","title":"European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2661277966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661277966?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:15","pubTimestamp":1787584528,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week slightly lower late Monday morning, declining 0.16% to 1,978.70 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera  and consumer goods company Unilever , which rose 1.9% and 1.8% respectively. They were followed by lender Banco Santander  and brewing company Anheuser-Busch InBev , which were up 1.2% and 1% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and biotech firm BioNTech , which dropped 5.1% and 4.2% respectively. They were followed by biopharmaceutical company argenx  and telecommunications company Nokia , which were down 2.8% and 2.6% respectively.The gainers from the UK were led by communications group WPP  and education company Pearson , which advanced 3.4% and 2.1% respectively. They were followed by alcoholic beverage company Diageo  and hospitality company Intercontinental H","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IEUR","BK4020","BK4142","BK4535","BK4548","BK4568","BK7142","BNTX","GSIB","WPP","NOK","BK4009","DEO","ARGX","EPV","NCNA","BK4111","SAN.AU","AFG","AUTL","BK4547","BUD.AU","LU0124676726.USD","UL","TBXU","ULVR.UK","WPP.AU","LU0320765992.SGD","SAN","BK4505","BK4117","FMED","IE00BJT1NW94.SGD","LU0006061336.USD","LFGY","BDRX","BK4183","IHG","OPRA","IBB","DGE.UK","BK4588","BUD","LNOK","CLLS","IE00BFTCPJ56.SGD","UN","BK4169","BK4023","PSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661742342","title":"Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages","url":"https://stock-news.laohu8.com/highlight/detail?id=2661742342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661742342?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:09","pubTimestamp":1787580540,"startTime":"0","endTime":"0","summary":"Shares of Cytek Biosciences fell after the company said it would challenge a jury's decision to make it pay $56 million in damages in a patent infringement case.The stock was down 7.2% at $4.47 Monday. Shares are now down 12% since the start of the year.The company said Friday that in a patent infringement lawsuit brought by Beckman Coulter, a jury found in Cytek's favor on three of four claims. On the remaining claim, the jury found no literal infringement, but did find infringement under the doctrine of equivalents.The jury awarded past damages consisting of $20 million in lost profit and $36.1 million in royalties. Cytek said it would pursue post-verdict motions challenging the jury's infringement finding and the related damages.Beckman Coulter had alleged that Cytek's Aurora flow cytometers violated Beckman's patent rights for technology used in its CytoFLEX platform.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0187121727.USD","LU0289960550.SGD","BK4533","LU0390134368.USD","SG9999001176.SGD","LU1023059063.AUD","LU0157215616.USD","LU2125909593.SGD","SGXZ57979304.SGD","LU0320765059.SGD","CTKB","BK4588","LU0109391861.USD","BK4534","LU0820561818.USD","BK4504","LU0689472784.USD","IE00BKVL7J92.USD","IE00BQXX3D17.EUR","LU0097036916.USD","LU2106854487.HKD","LU1551013425.SGD","LU1791710400.SGD","LU1551013342.USD","SG9999001176.USD","LU0820562030.AUD","IE0004445239.USD","IE000M9KFDE8.USD","LU0432979614.USD","LU2125910179.SGD","LU1057294990.SGD","SGXZ23171101.USD","IE00BZ1G4Q59.USD","SG9999013999.USD","FMED","LU0289961442.SGD","LU2244417387.USD","LU2355687059.USD","LU2211814178.USD","LU0289739343.SGD","DHR","LU1804176565.USD","LU2112291526.USD","BK4581","LU1917777945.USD","LU1267930730.SGD","LU1791710582.SGD","LU1923621640.USD","LU1923622614.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661820274","title":"Qiagen Names Jonathan Pratt as CEO, Effective Sept. 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661820274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661820274?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:45","pubTimestamp":1787579140,"startTime":"0","endTime":"0","summary":"Qiagen names Jonathan Pratt as CEO, effective Sept. 1Qiagen appointed Jonathan M. Pratt as CEO, effective Sept. 1, 2026.Pratt most recently ran Filtration Group through its sale to Parker-Hannifin in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL1Ktsf1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00BZ1G4Q59.USD","IE000M9KFDE8.USD","LU1989772840.SGD","LU0320765489.SGD","LU2106854487.HKD","SG9999013999.USD","BK4585","LU1974910355.USD","IE00BQXX3D17.EUR","LU2125910336.SGD","SG9999001176.USD","LU2265009873.SGD","LU0107464264.USD","LU0689472784.USD","LU0943347566.SGD","LU0256863902.USD","LU0109391861.USD","IE00BKVL7J92.USD","LU1923622614.USD","BK4533","LU1064131342.USD","LU1551013342.USD","IE00BQXX3F31.USD","LU0208291251.USD","SGXZ57979304.SGD","LU0320765059.SGD","LU2433249047.HKD","LU1791710400.SGD","LU2063271972.USD","IE0004445239.USD","LU2125910179.SGD","LU0528227936.USD","LU0289739343.SGD","SGXZ23171101.USD","QGEN","LU0157215616.USD","BK4121","PH","LU0211331839.USD","LU1804176565.USD","LU1267930730.SGD","LU0122379950.USD","BK4534","LU0820562030.AUD","LU2211814178.USD","FMED","LU0114720955.EUR","DHR","LU0511384066.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279382","title":"Canada's Nanalysis Q2 Revenue Edges up on Services Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279382","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279382?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:39","pubTimestamp":1787575186,"startTime":"0","endTime":"0","summary":"Canada's Nanalysis Q2 revenue edges up on services strengthOverviewCanada NMR spectrometer maker's Q2 revenue rose 1.5% yr/yr to C$9.7 mlnAdjusted EBITDA improved to C$0.9 mln from a loss in prior-yea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L0FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU2125909593.SGD","IE0004445239.USD","LU0289961442.SGD","LU1923621640.USD","SGXZ23171101.USD","BK4581","LU2063271972.USD","IE00BQXX3C00.GBP","LU0820562030.AUD","IE00BKVL7J92.USD","LU1974910355.USD","FMED","LU0289960550.SGD","SGXZ57979304.SGD","LU1791710400.SGD","SG9999001176.USD","LU0528227936.USD","LU0175139822.USD","LU0708995401.HKD","LU0943347566.SGD","LU2106854487.HKD","SG9999001176.SGD","LU0122379950.USD","BK4585","LU2125910179.SGD","LU1804176565.USD","LU2125910336.SGD","LU2355687059.USD","LU2125909247.SGD","LU0312595415.SGD","LU0320765059.SGD","LU0511384066.AUD","LU0097036916.USD","SG9999013999.USD","LU1057294990.SGD","LU1551013342.USD","LU0820561909.HKD","LU2023250504.SGD","LU2244417387.USD","LU0114720955.EUR","LU1366333091.USD","DHR","IE000M9KFDE8.USD","LU0107464264.USD","BK4533","LU1923622614.USD","LU2265009873.SGD","LU0289739343.SGD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661784220","title":"Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661784220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661784220?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:20","pubTimestamp":1787566808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Enliven Therapeutics (ELVN), Argenx Se (ARGX) and Aq...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-enliven-therapeutics-elvn-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-enliven-therapeutics-elvn-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235188.USD","BK4588","BK4007","IBB","LU2324357040.USD","LU0320765992.SGD","ARGX","ELVN","IE00BJT1NW94.SGD","BK4505","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4139","IE0002141913.USD","LU1983260115.SGD","BK4585","LU0889565916.HKD","LU0823416689.USD","IE0009355771.USD","LU0109394709.USD","FMED","IE00BFTCPJ56.SGD","TBXU","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661546290","title":"Cytek Owes Beckman Coulter $56 Mln in Cell-Analysis Patent Case, US Jury Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2661546290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661546290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:02","pubTimestamp":1787346151,"startTime":"0","endTime":"0","summary":"UPDATE 1-Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury saysAug 21 (Reuters)-A Delaware federal jury determined on Friday that Cytek Biosciences'CTKB.Oproducts for analyzing ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL6N44I12W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DHR","LU1791710400.SGD","LU0820561909.HKD","LU0320765059.SGD","BK4504","SG9999001176.USD","LU0097036916.USD","SGXZ23171101.USD","CTKB","LU0157215616.USD","LU1551013342.USD","IE00BQXX3F31.USD","LU1917777945.USD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1804176565.USD","LU0175139822.USD","LU0390134368.USD","LU0672654240.SGD","LU2125909593.SGD","LU0289960550.SGD","LU1366333091.USD","LU1974910355.USD","LU0107464264.USD","LU1551013425.SGD","LU2355687059.USD","BK4581","SGXZ57979304.SGD","LU0312595415.SGD","LU1791710582.SGD","LU0528227936.USD","LU2023250504.SGD","LU0109391861.USD","LU0882574055.USD","LU0432979614.USD","LU2211814178.USD","LU0708995401.HKD","LU2063271972.USD","LU1023059063.AUD","LU2244417387.USD","IE00BQXX3D17.EUR","LU2125909247.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","IE00BQXX3C00.GBP","LU2265009873.SGD","LU0289961442.SGD","LU1923622614.USD","FMED","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661266450","title":"William O'Neil Initiates Thermo Fisher Scientific at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661266450","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661266450?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:18","pubTimestamp":1787303883,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific (TMO) has an average rating of buy and mean price target of $643.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1720051017.SGD","LU2125909916.SGD","BK4121","LU1057294990.SGD","LU1720051108.HKD","LU2764263203.CNY","TMED","LU1791710582.SGD","IE00BJJMRZ35.SGD","LU0708994859.HKD","IE00B1BXHZ80.USD","LU2092937221.SGD","LU2357305700.SGD","LU1291159041.SGD","LU1280957306.USD","LU1712237335.SGD","BK4535","LU2125910336.SGD","TMO","LU1023059063.AUD","IE00BQXX3D17.EUR","BK4588","LU0342679015.USD","LU2125909247.SGD","LU1803068623.USD","LU1548497426.USD","LU2041044095.USD","LU1815333072.USD","LU1983299246.USD","IE00B19Z8W00.USD","LU0823416689.USD","LU0557290698.USD","LU2089984988.USD","LU0310800379.SGD","LU0061474960.USD","BK4534","GNMX","FMED","BK4533","LU1633808545.USD","LU0011850046.USD","LU0316494557.USD","HRTS","LU1791710400.SGD","LU1923621640.USD","LU1061106388.HKD","LU0128525929.USD","IE00B19Z9505.USD","LU0528227936.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661322172","title":"Revvity Inc. Stock Advances 3.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661322172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661322172?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Revvity Inc. rallied 3.9% to $124.13 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.9% to 7,641.16 and Dow Jones Industrial Average falling 1.3% to 52,759.21.This was the stock's second consecutive day of gains.Revvity Inc. hit a new 52-week high, surpassing its previous peak of $122.11, which the company achieved on August 19th.The stock outperformed some of its peers, as Danaher Corp. rose 2.1% to $215.91, IDEXX Laboratories Inc. fell 2.9% to $545.86, and Agilent Technologies Inc. rose 0.57% to $156.30.Trading volume totaled 2.3 million, compared to the 50-day average of 1.5 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU2355687059.USD","LU1057294990.SGD","LU1061106388.HKD","LU2404859741.USD","IE00BKVL7J92.USD","LU0289739343.SGD","LU2089279066.USD","BK4121","LU1791710400.SGD","A","LU1974910355.USD","IE00BLDYK493.USD","LU1941712264.USD","LU2112291526.USD","LU1791710582.SGD","RVTY","LU2041044095.USD","LU0097036916.USD","LU0820561818.USD","LU1804176565.USD","LU2063271972.USD","BK4567","LU0347712357.USD","LU0157215616.USD","BK4082","BK4504","LU1917777945.USD","LU0289961442.SGD","LU0109391861.USD","LU1941712348.USD","LU2125909247.SGD","FMED","SG9999013999.USD","IDXX","IE00BN0W2W23.USD","BK4585","LU0672654240.SGD","LU1923621640.USD","LU1165135440.EUR","LU2229751404.USD","BK4581","DHR","LU2125910336.SGD","LU0289960550.SGD","SGXZ23171101.USD","PAWZ","GB00B4QBRK32.GBP","LU1551013425.SGD","LU0175139822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661234283","title":"Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661234283","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661234283?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:03","pubTimestamp":1787256208,"startTime":"0","endTime":"0","summary":"Thermo Fisher CHRO Lisa P. Britt disposes of 11,440 common shares worth $7.01 millionLisa P. Britt, Sr. VP and Chief HR Officer, sold 11,440 Thermo Fisher shares on Aug. 19, 2026 at USD 613.12.Transac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLVzrkP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","LU2360108059.USD","LU1854104046.USD","LU1791710400.SGD","IE00BKPKM429.USD","LU1989771016.USD","LU2089984988.USD","LU1548497426.USD","TMO","IE00BQXX3D17.EUR","BK4585","LU0342679015.USD","BK4588","LU2543165471.USD","LU2433249047.HKD","GNMX","LU2125910179.SGD","LU0070302665.USD","LU2764262908.HKD","LU1064131342.USD","LU2468319806.SGD","LU2125909593.SGD","LU1267930573.SGD","LU0128525929.USD","LU0316494557.USD","LU1023059063.AUD","LU1988902786.USD","LU2720916845.USD","BK4548","IE00BJJMRZ35.SGD","LU2063271972.USD","BK4581","HRTS","LU0310800379.SGD","LU1623119135.USD","LU0266013472.USD","LU1983299246.USD","IE00B19Z9505.USD","LU2125909759.SGD","LU0957791311.USD","LU1720051017.SGD","LU1803068623.USD","LU1670627923.USD","LU1633808545.USD","LU2125909916.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","IE00BQXX3C00.GBP","FMED","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660826442","title":"Danaher Unit IDT Expands DNA Synthesis Capabilities to Support High-Diversity Assays","url":"https://stock-news.laohu8.com/highlight/detail?id=2660826442","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660826442?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:55","pubTimestamp":1787230539,"startTime":"0","endTime":"0","summary":"Danaher unit IDT expands DNA synthesis capabilities to support high-diversity assaysDanaher unit Integrated DNA Technologies expanded DNA synthesis capabilities to cover higher-diversity designs, larg","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL4Z6bb5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","SG9999013999.USD","LU0528227936.USD","LU0672654240.SGD","LU1923622614.USD","LU0187121727.USD","LU0122379950.USD","IE00BQXX3D17.EUR","IE00BKVL7J92.USD","LU0109391861.USD","LU1804176565.USD","LU2125909247.SGD","LU2244417387.USD","LU0689472784.USD","LU1791710582.SGD","LU1267930730.SGD","LU0114720955.EUR","LU1917777945.USD","SG9999001176.USD","BK4588","FMED","LU0289960550.SGD","LU0107464264.USD","IE00BQXX3F31.USD","LU0320765059.SGD","DHR","LU2112291526.USD","SGXZ57979304.SGD","LU2355687059.USD","LU0943347566.SGD","LU1551013425.SGD","LU0820561909.HKD","LU1974910355.USD","LU1023059063.AUD","BK4121","LU2265009873.SGD","BK4581","LU0157215616.USD","LU0432979614.USD","LU2125910336.SGD","LU1791710400.SGD","LU0312595415.SGD","IE0004445239.USD","LU1061106388.HKD","BK4504","LU0390134368.USD","LU0097036916.USD","LU2023250504.SGD","IE000M9KFDE8.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}